Effect of Treatment Naivete on MRI Outcomes with Fingolimod or Injectable Disease-Modifying Therapies in Patients with Multiple Sclerosis: PREFERMS

被引：0
|
作者：
Hunter, Samuel F. [1 ]
Thomas, Florian P. [2 ,3 ]
Meng, Xiangyi [4 ]
Schofield, Lesley [4 ]
Tenenbaum, Nadia [4 ]
Cree, Bruce A. C. [5 ]
机构：
[1] Adv Neurosci Inst, Franklin, TN USA
[2] Hackensack Univ Med Ctr, Hackensack, NJ USA
[3] Seton Hall Univ, Hackensack Meridian Sch Med, Nutley, NJ USA
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] UCSF Weill Inst Neurosci, San Francisco, CA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P037
引用
收藏
页码：35 / 36
页数：2
相关论文
共 50 条
  • [21] Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain
    Carole Dembek
    Leigh Ann White
    Jayson Quach
    Andrea Szkurhan
    Nazia Rashid
    M. R. Blasco
    The European Journal of Health Economics, 2014, 15 : 353 - 362
  • [22] Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies
    Grebenciucova, Elena
    Pruitt, Amy
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2017, 17 (11)
  • [23] Persistence to oral disease-modifying therapies in multiple sclerosis patients
    Simona Lattanzi
    Maura Danni
    Ruja Taffi
    Raffaella Cerqua
    Giulia Carlini
    Alessandra Pulcini
    Leandro Provinciali
    Mauro Silvestrini
    Journal of Neurology, 2017, 264 : 2325 - 2329
  • [24] Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain
    Dembek, Carole
    White, Leigh Ann
    Quach, Jayson
    Szkurhan, Andrea
    Rashid, Nazia
    Blasco, M. R.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (04): : 353 - 362
  • [25] Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies
    Elena Grebenciucova
    Amy Pruitt
    Current Neurology and Neuroscience Reports, 2017, 17
  • [26] Persistence to oral disease-modifying therapies in multiple sclerosis patients
    Lattanzi, Simona
    Danni, Maura
    Taffi, Ruja
    Cerqua, Raffaella
    Carlini, Giulia
    Pulcini, Alessandra
    Provinciali, Leandro
    Silvestrini, Mauro
    JOURNAL OF NEUROLOGY, 2017, 264 (11) : 2325 - 2329
  • [27] Discontinuing disease-modifying multiple sclerosis therapies
    Krysko, Kristen
    LANCET NEUROLOGY, 2023, 22 (07): : 543 - 545
  • [28] Emerging multiple sclerosis disease-modifying therapies
    Giacomini, Paul S.
    Darlington, Peter J.
    Bar-Or, Amit
    CURRENT OPINION IN NEUROLOGY, 2009, 22 (03) : 226 - 232
  • [29] Emerging Disease-Modifying Therapies in Multiple Sclerosis
    Perumal, Jai
    Khan, Omar
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2012, 14 (03) : 256 - 263
  • [30] Cost of disease-modifying therapies for multiple sclerosis
    Brown, Murray G.
    NEUROLOGY, 2015, 84 (21) : E181 - E185
12345